Stockscreener 앱 받기
7.295
3.77%
0.265
Cullinan Therapeutics Inc 주식(CGEM)의 최신 뉴스
Key resistance and support levels for Cullinan Therapeutics Inc.Insider Strategy for High Conviction Picks - Newser
Is Cullinan Therapeutics Inc. stock reversal real or fakeFree Daily Top Performing Stock Insights - Newser
Why Cullinan Therapeutics Inc. stock attracts strong analyst attentionSector-Wise Stock Strength Trend Analysis - Newser
Is Cullinan Therapeutics Inc. showing signs of accumulationConservative Equity Setup with Signal Analysis - Newser
Is Cullinan Therapeutics Inc. stock poised for growthWeekly Chart Watchlist with Trade Guidance - Newser
Cullinan (CGEM) Q2 R&D Jumps 68% - AOL.com
Full technical analysis of Cullinan Therapeutics Inc. stockLong-Term Growth Trend Summary With Confidence - Newser
Cullinan Therapeutics Inc. stock trend outlook and recovery pathSecure Asset Flow and Trend Pattern Analysis - Newser
How to track smart money flows in Cullinan Therapeutics Inc.Stock Market Trend and Pattern Analysis - Newser
Using Ichimoku Cloud for Cullinan Therapeutics Inc. technicalsDay Trading Setup and Momentum Analysis - Newser
How Cullinan Therapeutics Inc. stock performs during market volatilityRisk-Managed Swing Setup and Signal Analysis - Newser
Cullinan Therapeutics: Q2 Earnings Snapshot - Greenwich Time
Cullinan Therapeutics Reports Q2 2025 Financial Results - TipRanks
What to expect from Cullinan Therapeutics Inc. in the next 30 daysPrice Movement and Market Sentiment Analysis - Newser
Can swing trading help recover from Cullinan Therapeutics Inc. lossesAI Generated Momentum Stock Forecast Guide - Newser
Cullinan Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cullinan Therapeutics reports Q2 EPS ($1.07), consensus (86c) - TipRanks
Cullinan Therapeutics Reports Wider-Than-Expected Q2 LossNews and Statistics - IndexBox
Cullinan Therapeutics (CGEM) to Release Earnings on Thursday - Defense World
Cullinan Management Appoints New Board Members - TipRanks
Cullinan Therapeutics Q2 net loss widens to $70.1 mln on higher R&D costs - MarketScreener
Cullinan Therapeutics, Inc. SEC 10-Q Report - TradingView
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - The Manila Times
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire Inc.
Real time social sentiment graph for Cullinan Therapeutics Inc.Swing Trade Timing with Daily Forecast - Newser
How to manage a losing position in Cullinan Therapeutics Inc.Breakout Monitoring with Momentum Analysis - Newser
Using data models to predict Cullinan Therapeutics Inc. stock movementFree Momentum Based Equity Trading Plan - Newser
When is Cullinan Therapeutics Inc. stock expected to show significant growthConsistently profitable trades - Jammu Links News
Why is Cullinan Therapeutics Inc. stock attracting strong analyst attentionFree Stock Market Knowledge Sharing - Jammu Links News
How many analysts rate Cullinan Therapeutics Inc. as a “Buy”Free Bull & Bear Market Updates - Jammu Links News
Is it the right time to buy Cullinan Therapeutics Inc. stockGet exclusive access to expert stock recommendations - Jammu Links News
Is Cullinan Therapeutics Inc. stock overvalued or undervaluedUnlock powerful trading tools for investors - Jammu Links News
Market reaction to Cullinan Therapeutics Inc.’s recent newsSwing Entry Risk Mitigation with Chart Analysis - newser.com
What catalysts could drive Cullinan Therapeutics Inc. stock higher in 2025Build a portfolio that outperforms consistently - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):